US Trial Shows AstraZeneca Vaccine Is Safe and Effective
AstraZeneca Vaccine Shown to Be 79% Effective
A US trial found that the COVID-19 vaccine developed by AstraZeneca (AZN) and Oxford University is safe and highly effective. The 32,449-person trial showed that the vaccine is 79% effective against symptomatic illness and 100% effective at preventing severe illness and hospitalization.
European Countries Restart Distribution After Safety Concerns
A number of countries paused use of the shot due to reports that some people had developed blood clots after receiving the vaccine. But the results of the US AstraZeneca trial were published yesterday, , and have shown that the shot is safe.
The World Health Organization and the International Society on Thrombosis and Hemostasis have recommended that governments resume distribution of the AstraZeneca vaccine. Countries including France, Italy, and Germany have started giving out the shot again.
Emergency Use Authorization in the US
Now that results of the trial are out, AstraZeneca plans to file for emergency use authorization of its vaccine in the US early next month. AstraZeneca says that if the FDA approves the shot, it will be ready to distribute 30 million doses in the US immediately.
COVID-19 vaccine rollout is progressing steadily in the US. Over 44 million people in the country are already fully vaccinated, which is about 13.3% of the US population. Soon, one more safe and effective vaccine candidate will likely be available.
Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi. These links are provided for informational purposes and should not be viewed as an endorsement. No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.